Prestige Consumer Healthcare (PBH) Common Equity (2011 - 2025)

Prestige Consumer Healthcare's Common Equity history runs 15 years deep, the most recent figure standing at $1.8 billion for Q4 2025.

• On a quarterly basis, Common Equity rose 2.29% year-over-year to $1.8 billion in Q4 2025; TTM through Dec 2025 was $1.8 billion, a 2.29% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 10.86% from the prior year.
• Common Equity steadied at $1.8 billion in Q4 2025 per PBH's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.9 billion in Q2 2025 and bottomed at $1.4 billion in Q1 2021.
• The 5-year median for Common Equity is $1.6 billion (2022), against an average of $1.6 billion.
• Across the five-year window, Common Equity advanced 16.15% in 2022 and dropped 8.27% in 2023, its largest moves.
• Year by year, Common Equity stood at $1.5 billion in 2021, then rose by 11.1% to $1.7 billion in 2022, then dropped by 5.12% to $1.6 billion in 2023, then increased by 11.74% to $1.8 billion in 2024, then gained by 2.29% to $1.8 billion in 2025.
• Per Business Quant, the three latest PBH Common Equity figures stand at $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025).